现在爱荷华州的影响生命血液中心通过光线进行无痛、非侵入性血红蛋白筛查,以减少不适和浪费。 Iowa's ImpactLife blood center now uses painless, non-invasive hemoglobin screening via light, reducing discomfort and waste.

影响生命 — — 爱荷华的血液中心 — — 已开始使用OrSense(OrSense)。 OrSense(OrSense)是一个非侵入性装置,用光测量皮肤中的血红蛋白,消除了在捐赠者筛查过程中对手指刺的需求。 ImpactLife, a blood center in Iowa, has started using OrSense, a non-invasive device that measures hemoglobin through the skin using light, eliminating the need for finger pricks during donor screening. 这一技术现在活跃在爱荷华市达文波特和锡达拉皮兹市,它减少了不适,减少了生物危害废物,改善了捐赠经验。 The technology, now active in Davenport, Iowa City, and Cedar Rapids, reduces discomfort, cuts down on biohazard waste, and improves the donation experience. 该系统预定在2025年10月底前扩大到所有影响生命地点,目的是提高捐助者的投票率,同时保持准确性和安全标准。 The system is set to expand to all ImpactLife locations by late October 2025, aiming to boost donor turnout while maintaining accuracy and safety standards.